Company Profiles

driven by the PitchBook Platform

Aomics

Description

Developer of an anti-cancer drug. The company develops a anti-cancer drug by fusing an antibody to the paclitaxel molecule.

2015

Founded

PRIVATE

Status

Accelerator/Inc

Latest Deal Type

1

Investors

Description

Developer of an anti-cancer drug. The company develops a anti-cancer drug by fusing an antibody to the paclitaxel molecule.

Ownership Status

Privately held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Drug Discovery

Primary Office

2351 Faraday Avenue Carlsbad, CA 92008United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aomics's full profile, request a free trial.

    Aomics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aomics Investors (1)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Bio, Tech and BeyondAccelerator/Incubator000 0000000 0000
    Bio, Tech and Beyond Accelerator/Incubator

    Aomics Executive Team (1)

    NameTitleBoard
    Seat
    Contact
    Info
    Shaochun SongFounder & President
    Shaochun Song Founder & President
    Request full access to PitchBook